Randomized Maintenance Therapy with Azacitidine (Vidaza) in Older Patients (>= 60 years of age) with Acute Myeloid Leukemia (AML) and Refractory Anemia with Excess of Blasts (RAEB, RAEB-t). Results of the HOVON97 Phase III Randomized Multicentre Study (EudraCT 2008-001290-15)

Geert Huls; Dana Chitu; Violaine Havelange; Mojca Jongen-Lavrencic; Arjen van de Loosdrecht; Bart J. Biemond; Harm Sinnege; Beata Hodossy; Carlos Graux; Marinus van Marwijk Kooij; Okke de Weerdt; Dimitri Breems; Saskia Klein; Jurgen Kuball; Gert J. Ossenkoppele; Bob Lowenberg; Edo Vellenga

Randomized Maintenance Therapy with Azacitidine (Vidaza) in Older Patients (>= 60 years of age) with Acute Myeloid Leukemia (AML) and Refractory Anemia with Excess of Blasts (RAEB, RAEB-t). Results of the HOVON97 Phase III Randomized Multicentre Study (EudraCT 2008-001290-15)

Geert Huls, Dana Chitu, Violaine Havelange, Mojca Jongen-Lavrencic, Arjen van de Loosdrecht, Bart J. Biemond, Harm Sinnege, Beata Hodossy, Carlos Graux, Marinus van Marwijk Kooij, Okke de Weerdt, Dimitri Breems, Saskia Klein, Jurgen Kuball, Gert J. Ossenkoppele, Bob Lowenberg, Edo Vellenga

Onderzoeksoutput › Academic

Originele taal-2	English
Aantal pagina's	3
Tijdschrift	Blood
Volume	130
Status	Published - 7-dec.-2017
Evenement	59th Annual Meeting of the American-Society-of-Hematology (ASH) - Atlanta, United States Duur: 9-dec.-2017 → 12-dec.-2017

Handle.net

Permanente koppeling

Citeer dit

Huls, G., Chitu, D., Havelange, V., Jongen-Lavrencic, M., van de Loosdrecht, A., Biemond, B. J., Sinnege, H., Hodossy, B., Graux, C., Kooij, M. V. M., de Weerdt, O., Breems, D., Klein, S., Kuball, J., Ossenkoppele, G. J., Lowenberg, B., & Vellenga, E. (2017). Randomized Maintenance Therapy with Azacitidine (Vidaza) in Older Patients (>= 60 years of age) with Acute Myeloid Leukemia (AML) and Refractory Anemia with Excess of Blasts (RAEB, RAEB-t). Results of the HOVON97 Phase III Randomized Multicentre Study (EudraCT 2008-001290-15). Blood, 130.

@article{dc393105119940d58e9b3fc2fa219b88,

title = "Randomized Maintenance Therapy with Azacitidine (Vidaza) in Older Patients (>= 60 years of age) with Acute Myeloid Leukemia (AML) and Refractory Anemia with Excess of Blasts (RAEB, RAEB-t). Results of the HOVON97 Phase III Randomized Multicentre Study (EudraCT 2008-001290-15)",

author = "Geert Huls and Dana Chitu and Violaine Havelange and Mojca Jongen-Lavrencic and \{van de Loosdrecht\}, Arjen and Biemond, \{Bart J.\} and Harm Sinnege and Beata Hodossy and Carlos Graux and Kooij, \{Marinus van Marwijk\} and \{de Weerdt\}, Okke and Dimitri Breems and Saskia Klein and Jurgen Kuball and Ossenkoppele, \{Gert J.\} and Bob Lowenberg and Edo Vellenga",

year = "2017",

month = dec,

day = "7",

language = "English",

volume = "130",

journal = "Blood",

issn = "0006-4971",

publisher = "AMER SOC HEMATOLOGY",

note = "59th Annual Meeting of the American-Society-of-Hematology (ASH) ; Conference date: 09-12-2017 Through 12-12-2017",

}

Huls, G, Chitu, D, Havelange, V, Jongen-Lavrencic, M, van de Loosdrecht, A, Biemond, BJ, Sinnege, H, Hodossy, B, Graux, C, Kooij, MVM, de Weerdt, O, Breems, D, Klein, S, Kuball, J, Ossenkoppele, GJ, Lowenberg, B & Vellenga, E 2017, 'Randomized Maintenance Therapy with Azacitidine (Vidaza) in Older Patients (>= 60 years of age) with Acute Myeloid Leukemia (AML) and Refractory Anemia with Excess of Blasts (RAEB, RAEB-t). Results of the HOVON97 Phase III Randomized Multicentre Study (EudraCT 2008-001290-15)', Blood, vol. 130.

Randomized Maintenance Therapy with Azacitidine (Vidaza) in Older Patients (>= 60 years of age) with Acute Myeloid Leukemia (AML) and Refractory Anemia with Excess of Blasts (RAEB, RAEB-t). Results of the HOVON97 Phase III Randomized Multicentre Study (EudraCT 2008-001290-15). / Huls, Geert; Chitu, Dana; Havelange, Violaine et al.
In: Blood, Vol. 130, 07.12.2017.

Onderzoeksoutput › Academic

TY - JOUR

T1 - Randomized Maintenance Therapy with Azacitidine (Vidaza) in Older Patients (>= 60 years of age) with Acute Myeloid Leukemia (AML) and Refractory Anemia with Excess of Blasts (RAEB, RAEB-t). Results of the HOVON97 Phase III Randomized Multicentre Study (EudraCT 2008-001290-15)

AU - Huls, Geert

AU - Chitu, Dana

AU - Havelange, Violaine

AU - Jongen-Lavrencic, Mojca

AU - van de Loosdrecht, Arjen

AU - Biemond, Bart J.

AU - Sinnege, Harm

AU - Hodossy, Beata

AU - Graux, Carlos

AU - Kooij, Marinus van Marwijk

AU - de Weerdt, Okke

AU - Breems, Dimitri

AU - Klein, Saskia

AU - Kuball, Jurgen

AU - Ossenkoppele, Gert J.

AU - Lowenberg, Bob

AU - Vellenga, Edo

PY - 2017/12/7

Y1 - 2017/12/7

M3 - Meeting Abstract

SN - 0006-4971

VL - 130

JO - Blood

JF - Blood

T2 - 59th Annual Meeting of the American-Society-of-Hematology (ASH)

Y2 - 9 December 2017 through 12 December 2017

ER -

Huls G, Chitu D, Havelange V, Jongen-Lavrencic M, van de Loosdrecht A, Biemond BJ et al. Randomized Maintenance Therapy with Azacitidine (Vidaza) in Older Patients (>= 60 years of age) with Acute Myeloid Leukemia (AML) and Refractory Anemia with Excess of Blasts (RAEB, RAEB-t). Results of the HOVON97 Phase III Randomized Multicentre Study (EudraCT 2008-001290-15). Blood. 2017 dec. 7;130.